Health Care

Mayor Bill de Blasio said he wants to make sure under-served communities get the healthcare resources they need to deal with long-term COVID symptoms.

COVID-19 infections and related illnesses were responsible for roughly 345,000 deaths in 2020.

Kidney patients have been vaccine-eligible in New Jersey since Jan. 14. But the state said it cannot give a vaccine supply to kidney clinics because it doesn't have enough shots to go around.

A phase 3 trial shows Regeneron's REGEN-COV cocktail reduced hospitalization or death by 70% in non-hospitalized COVID-19 patients. It also significantly shortens the duration of symptoms by four days, the trial showed.

The Cuomo administration's policy, similar to nursing homes, allowed asymptomatic patients to return to group homes. An advisory in April 2020 said no individual would be denied readmission or admission based solely on a confirmed or suspected diagnosis if they could be safely accommodated.

As the coronavirus made an end-of-the-year surge across New York, some nursing homes proved especially helpless at stopping the spread of COVID-19, despite having nine months to stockpile protective equipment and refine preventative measures.

For so-called coronavirus 'long-haulers,' or those suffering from symptoms months after being infected with the virus, the lasting effects can be debilitating and different for each person.

Many families are calling on officials to loosen visitation restrictions at nursing homes and other long-term care facilities.

Three variants of the virus that causes COVID-19 are already spreading in New York, which is relying on its travel policy and contact tracing to prevent people coming from lax states from spreading the virus and variants here.

The New York Senate has passed a bill to limit the governor’s emergency powers at a time when he’s facing sexual harassment allegations and scrutiny over his administration’s reporting of COVID-19 deaths at nursing homes.

The first wave of coronavirus crushed the tristate New York area. The rest of the country would be next.

The prescription drug Imcivree is approved for three specific genetic diseases, which affect approximately 1,000 to 2,000 patients in the United States.